Grare, M., Mourer, M., Fontanay, S., Regnouf-De-Vains, J.B., Finance, C., Duval, R.E., In vitro activity of paraguanidinoethylcalix[4]arene against susceptible and antibioticresistant Gram-negative and Gram-positive bacteria (2007) J. Antimicrob. Chemother., 60 (3), pp. 575-581; Lipsky, B.A., Itani, K., Norden, C., Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of Linezolid versus Ampicillin-Sulbactam/Amoxicillin-Clavulanate (2004) Clin. Infect. Dis., 38 (1), pp. 17-24; De Kraker, M.E.A., Davey, P.G., Grundmann, H., Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: Estimating the burden of antibiotic resistance in Europe (2011) Plos. Med., 8 (10), pp. 1-8; Carlet, J., Collignon, P., Goldmann, D., Goossens, H., Gyssens, I.C., Harbarth, S., Jarlier, V., Voss, A., Society’s failure to protect a precious resource: antibiotics (2011) Lancet., 378, pp. 369-371; Grant, S.S., Hung, D.T., Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response (2013) Virulence, 4 (4), pp. 273-283; Desai, N.C., Rajpara, K.M., Joshi, V.V., Synthesis of pyrazole encompassing 2-pyridone derivatives as antibacterial agents (2013) Bioorg. Med. Chem. Lett., 23, pp. 2714-2717; Alekshun, M.N., Levy, S.B., Molecular mechanisms of antibacterial multidrug resistance (2007) Cell, 128, pp. 1037-1050; Brown, E.D., Wright, G.D., Antibacterial drug discovery in the resistance era (2016) Nature, 529 (7586), pp. 336-343; Kristiansson, E., Fick, J., Janzon, A., Grabic, R., Rutgersson, C., Weijdegard, B., Soderstrom, H., Larsson, D.G., Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements (2011) Plos. One, 6; (2014) Antimicrobial Resistance, , http://www.who.int/drugresistance/documents/surveillancereport/en; Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Jr., Gilbert, D., Rice, L.B., Scheld, M., Bartlett, J., Bad Bugs, no drugs: No ESKAPE! An update from the infectious diseases Society of America (2009) Clin. Infect. Dis., 48 (1), pp. 1-12; Rice, L.B., Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE (2008) J. Infect. Dis., 197, pp. 1079-1081; Tillotson, G.S., Zinner, S.H., Burden of antimicrobial resistance in an era of decreasing susceptibility (2017) Expert Rev. Anti Infect. Ther., 13, pp. 1-14; Clatworthy, A.E., Pierson, E., Hung, D.T., Targeting virulence: a new paradigm for antimicrobial therapy (2007) Nat. Chem. Biol., 3, pp. 541-548; Hao, H., Cheng, G., Iqbal, Z., Ai, X., Hussain, H.I., Huang, L., Dai, M., Yuan, Z., Benefits and risks of antimicrobial use in food-producing animals (2014) Front Microbiol., 5, p. 288; Barriere, S.L., Clinical, economic and societal impact of antibiotic resistance (2015) Expert Opin. Pharmacother., 16 (2), pp. 151-153; Pontes, D.S., Pinheiro, F.A., Lima-Bittencourt, C.I., Guedes, R.L., Cursino, L., Barbosa, F., Santos, F.R., Nascimento, A.M., Multiple antimicrobial resistance of Gramnegative bacteria from natural oligotrophic lakes under distinct anthropogenic influence in a tropical region (2009) Microb. Ecol., 58 (4), pp. 762-772; D’Costa, V.M., Griffiths, E., Wright, G.D., Expanding the soil antibiotic resistome: Exploring environmental diversity (2007) Curr. Opin. Microbiol., 10, pp. 481-489; Martinez, J.L., Antibiotics and antibiotic resistance genes in natural environments (2008) Science, 321 (18), pp. 365-367; Knapp, C.W., Callan, A.C., Aitken, B., Shearn, R., Koenders, A., Hinwood, A., Relationship between antibiotic resistance genes and metals in residential soil samples from Western Australia (2017) Environ. Sci. Pollut. Res. Int., 24 (3), pp. 2484-2494; Shafaati, M., Boroumand, M., Nowroozi, J., Amiri, P., Kazemian, H., Correlation between qacE and qacEΔ1 efflux pump genes, antibiotic and disinfectant resistant among clinical isolates of E.Coli (2016) Recent Pat. Antiinfect. Drug Discov., 11 (2), pp. 189-195; Fernandez-Lopez, R., De Toro, M., Moncalian, G., Garcillan-Barcia, M.P., De La Cruz, F., Comparative genomics of the conjugation region of F-like plasmids: Five shades of F (2016) Front Mol. Biosci., 3 (71), pp. 1-14; De La Cruz, F., Davies, J., Horizontal gene transfer and the origin of species: Lessons from bacteria (2000) Trends Microbiol., 8 (3), pp. 128-133; Davies, J., Davies, D., Origins and evolution of antibiotic resistance (2010) Microbiol. Mol. Biol. Rev., 74 (3), pp. 417-433; Džidić, S., Šušković, J., Kos, B., Antibiotic resistance mechanisms in bacteria: Biochemical and genetic aspects (2008) Food Technol. Biotechnol., 46 (1), pp. 11-21; Hughes, D., Andersson, D.I., Environmental and genetic modulation of the phenotypic expression of antibiotic resistance (2017) FEMS Microbiol. Rev., 41 (3), pp. 374-391; Hu, Y., Yang, X., Li, J., Lv, N., Liu, F., Wu, J., Lin, I.Y.C., Zhu, B., The bacterial mobile resistome transfer network connecting the animal and human microbiomes (2016) Appl. Environ. Microbiol., 82 (22), pp. 6672-6681; D'costa, V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W., Schwarz, C., Froese, D., Poinar, H.N., Wright, G.D. Antibiotic resistance is ancient (2011) Nature, 477 (7365), pp. 457-461; Perron, G.G., Whyte, L., Turnbaugh, P.J., Goordial, J., Hanage, W.P., Dantas, G., Desai, M.M., Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics (2015) Plos One, 10 (3), pp. 1-19; Santiago-Rodriguez, T.M., Fornaciari, G., Luciani, S., Dowd, S.E., Toranzos, G.A., Marota, I., Cano, R.J., Gut microbiome of an 11th century A.D. pre-columbian andean mummy (2015) Plos One, 10 (9), pp. 1-23; Rascovan, N., Telke, A., Raoult, D., Rolain, J.M., Desnues, C., Exploring divergent antibiotic resistance genes in ancient metagenomes and discovery of a novel beta-lactamase family (2016) Environ. Microbiol. Rep., 8 (5), pp. 886-895; Lugli, G.A., Milani, C., Mancabelli, L., Turroni, F., Ferrario, C., Duranti, S., Van Sinderen, D., Ventura, M., Ancient bacteria of the Otzi's microbiome: A genomic tale from the copper age (2017) Microbiome, 5 (1), pp. 1-18; Olaitan, A.O., Rolain, J.M., Ancient resistome (2016) Microbiol. Spectr., 4 (4), pp. 1-4; Davies, J., Inactivation of antibiotics and the dissemination of resistance genes (1994) Science, 264 (5157), pp. 375-382; Leclercq, R., Canton, R., Brown, D.F., Giske, C.G., Heisig, P., Macgowan, A.P., Mouton, J.W., Kahlmeter, G., EUCAST expert rules in antimicrobial susceptibility testing (2013) Clin. Microbiol. Infect., 19 (2), pp. 141-160; Llanes, C., Pourcel, C., Richardot, C., Plesiat, P., Fichant, G., Jean-Didier, C., Merens, A., Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: A French multicentre study on behalf of the GERPA Study Group (2013) J. Antimicrob. Chemother., 68, pp. 1763-1771; Jackson, R.W., Vinatzer, B., Arnold, D.L., Dorus, S., Murillo, J., The influence of the accessory genome on bacterial pathogen evolution (2011) Mob. Genet. Elements., 1 (1), pp. 55-65; Garcia-Aljaro, C., Balleste, E., Muniesa, M., Beyond the canonical strategies of horizontal gene transfer in prokaryotes (2017) Curr. Opin. Microbiol., 7 (38), pp. 95-105; Motta, S.S., Cluzel, P., Aldana, M., Adaptive resistance in bacteria requires epigenetic inheritance, genetic noise, and cost of efflux pumps (2015) Plos. One, 10 (3); Poole, K., Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria (2012) Trends Microbiol., 20, pp. 227-234; Krzyzanski, W., Rao, G.G., Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B (2017) Plos. One, 12 (3), pp. 1-17; Fernandez, L., Hancock, R.E.W., Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance (2012) Clin. Microbiol. Rev., 25 (4), pp. 661-681; Dar, D., Sorek, R., Regulation of antibiotic-resistance by noncoding RNAs in bacteria (2017) Curr. Opin. Microbiol., 36, pp. 111-117; Galan, J.C., Gonzalez-Candelas, F., Rolain, J.M., Canton, R., Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β -lactamases world (2013) Front Microbiol., 4 (9), pp. 1-17; Holloway, B.W., Asche, L.V., Mechanisms and clinical implications of antibiotic resistance in bacteria (1977) Drugs, 14 (4), pp. 283-290; Wright, G.D., Antibiotic adjuvants: Rescuing antibiotics from resistance (2016) Trend Microbiol., 24 (11), pp. 862-871; Borges, A., Saavedra, M.J., Simoes, M., Insights on antimicrobial resistance, biofilms and the use of phytochemicals as new antimicrobial agents (2015) Curr. Med. Chem., 22, pp. 2590-2614; Flemming, H.C., Wingender, J., The biofilm matrix (2010) Nat. Rev. Microbiol., 8, pp. 623-633; Delcour, A.H., Outer membrane permeability and antibiotic resistance (2009) Biochim. Biophys. Acta, 1794 (5), pp. 808-816; Piddock, L.J.V., Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria (2006) Clin. Microbiol. Rev., 19, pp. 382-402; Webber, M.A., Piddock, L.J.V., The importance of efflux pumps in bacterial antibiotic resistance (2003) J. Antimicrob. Chemother., 51, pp. 9-11; Floyd, J.L., Smith, K.P., Kumar, S.H., Floyd, J.T., Varela, M.F., LmrS Is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus (2010) Antimicrob. Agents Chemother., 54, pp. 5406-5412; Hu, R.M., Liao, S.T., Huang, C.C., Huang, Y.W., Yang, T.C., An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in Stenotrophomonas maltophilia (2012) Plos One, 7 (12); Ogawa, W., Onishi, M., Ni, R.T., Tsuchiya, T., Kuroda, T., Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae (2012) Gene, 498, pp. 177-182; Wright, G.D., Molecular mechanisms of antibiotic resistance (2011) Chem. Commun., 47, pp. 4055-4061; Livermore, D.M., Defining an extended-spectrum beta-lactamase (2008) Clin. Microbiol. Infect., 14, pp. 3-10; Nordmann, P., Poirel, L., Walsh, T.R., Livermore, D.M., The emerging NDM carbapenemases (2011) Trends Microbiol., 19, pp. 588-595; Voulgari, E., Poulou, A., Koumaki, V., Tsakris, A., Carbapenemase-producing Enterobacteriaceae: Now that the storm is finally here, how Will timely detection help us fight back (2013) Future Microbiol., 8, pp. 27-39; Woodford, N., Turton, J.F., Livermore, D.M., Multiresistant Gramnegative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance (2011) FEMS Microbiol., 35, pp. 736-755; Dzidic, S., Suskovic, J., Kos, B., Antibiotic resistance mechanisms in bacteria: Biochemical and genetic aspects (2008) Food Technol. Biotechnol., 46, pp. 11-21; Donlan, R.M., Biofilms: Microbial life on surfaces (2002) Emerg. Infect. Dis., 8, pp. 881-890; Stewart, P.S., Mechanisms of antibiotic resistance in bacterial biofilms (2002) Int. J. Med. Microbiol., 292, pp. 107-113; Stewart, P.S., Costerton, J.W., Antibiotic resistance of bacteria in biofilms (2001) Antibiot. Resist. Bact. Biofilms., 358, pp. 135-138; Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J., Greenberg, E.P., Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms (2000) Nature, 407, pp. 762-764; De La Fuente-Nunez, C., Reffuveille, F., Fernandez, L., Hancock, R., Bacterial biofilm development as a multicellular adaptation: Antibiotic resistance and new therapeutic strategies (2013) Curr. Opin. Microbiol., 16, pp. 580-589; Bordi, C., De Bentzmann, S., Hacking into bacterial biofilms: A new therapeutic challenge (2011) Ann. Intensive Care, 1 (19), pp. 1-8; Mah, T.F., O’Toole, G.A., Mechanisms of biofilm resistance to antimicrobial agents (2001) Trends Microbiol., 9, pp. 34-39; Donlan, R.M., Closterton, J.W., Biofilms: Survival mechanisms of clinically relevant microorganisms (2002) Clin. Microbiol. Rev., 15, pp. 167-193; Antunes, L.C., Ferreira, R.B., Buckner, M.M., Finlay, B.B., Quorum sensing in bacterial virulence (2010) Microbiology, 156, pp. 2271-2282; Gill, E.E., Franco, O.L., Hancock, R.E.W., Antibiotic adjuvants: Diverse strategies for controlling drug-resistant pathogens (2015) Chem. Biol. Drug Des., 85 (1), pp. 56-78; Livermore, D.M., Has the era of untreatable infections arrived? (2009) J. Antimicrob. Chemother., 64, pp. i29-i36; Arias, C.A., Murray, B.E., Antibiotic-resistant bugs in the 21st century -a clinical super-challenge (2009) N. Engl. J. Med., 360, pp. 439-443; Hancock, R.E.W., Nijnik, A., Philpott, D.J., Modulating immunity as a therapy for bacterial infections (2012) Nat. Rev. Microbiol., 10, pp. 243-254; Nigama, A., Guptab, D., Sharma, A., Treatment of infectious disease: Beyond antibiotics (2014) Microbiol. Res., 169, pp. 643-651; Pena, O.M., Hancock, D.G., Lyle, N.H., Linder, A., Russell, J.A., Xia, J., Fjell, C.D., Hancock, R.E.W., An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation (2014) E. Bio. Medicine., 1, pp. 64-71; Brown, D., Antibiotic resistance breakers: Can repurposed drugs fill the antibiotic discovery void? (2015) Nat. Rev. Drug Discov., pp. 1-12; Kalan, L., Wright, G.D., Antibiotic adjuvants: Multicomponent antiinfective strategies (2011) Expert Rev. Mol. Med., 13, pp. 1-17; Ejim, L., Farha, M.A., Falconer, S.B., Wildenhain, J., Coomber, B.K., Tyers, M., Brown, E.D., Wright, G.D., Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy (2011) Nat. Chem. Biol., 7, pp. 348-350; Bernal, P., Molina-Santiago, C., Daddaoua, A., Llamas, M.A., Antibiotic adjuvants: Identification and clinical use (2013) Microb. Biotechnol., 6 (5), pp. 445-449; Farha, M.A., Brown, E.D. Discovery of antibiotic adjuvants (2013) Nat. Biotechnol., 31 (2), pp. 120-122; Pillai, S., Moellering, R.C., Eliopoulos, G.M., Antimicrobial combinations (2005) Antibiotics in Laboratory Medicine, , (5th edn) Lorian, V, Lippincott Williams & Wilkins, Philadelphia; Mazumdar, K., Asok Kumar, K., Dutta, N.K., Potential role of the cardiovascular non-antibiotic (Helper compound) amlodipine in the treatment of microbial infections: Scope and hope for the future (2010) Int. J. Antimicrob. Agents, 36, pp. 295-302; Dasgupta, A., Chaki, S., Mukherjee, S., Lourduraja, J., Mazumdar, K., Dutta, N.K., Dastidar, S.G., Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine (2010) Eur. J. Clin. Microbiol. Infect. Dis., 29 (2), pp. 239-243; Fukuda, T., Matsumoto, A., Takahashi, Y., Tomoda, H., Omura, S., Phenatic acids A and B, new potentiators of antifungal miconazole activity produced by Streptomyces sp. K03-0132 (2005) J. Antibiot., 58 (4), pp. 252-259; Sun, L., Sun, S., Cheng, A., Wu, X., Zhang, Y., Lou, H., In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans (2009) Antimicrob. Agents Chemother., 53, pp. 1586-1591; Yamazaki, H., Omura, S., Tomoda, H., Xanthoradone C, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2 (2010) J. Antibiot., 63, pp. 329-330; De Pascale, G., Wright, G.D., Antibiotic resistance by enzyme inactivation: From mechanisms to solutions (2010) Chem. Bio. Chem., 11, pp. 1325-1334; Shlaes, D.M., New β-lactam-β-lactamase inhibitor combinations in clinical development (2013) Ann. NY Acad. Sci., 1277, pp. 105-114; Bush, K., Improving known classes of antibiotics: An optimistic approach for the future (2012) Curr. Opin. Pharmacol., 12, pp. 527-534; Abuzaid, A., Hamouda, A., Amyes, S.G., Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance (2012) J. Hosp. Infect., 81, pp. 87-91; Bhardwaj, A.K., Mohanty, P., Bacterial efflux pumps involved in multidrug resistance and their inhibitors: Rejuvenating the antimicrobial chemotherapy (2012) Recent Pat. Antiinfect. Drug Discov., 7, pp. 73-89; Li, X.Z., Plesiat, P., Nikaido, H., The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria (2015) Clin. Microbiol. Rev., 28 (2), pp. 337-418; Urakawa, H., Yamada, K., Komagoe, K., Ando, S., Oku, H., Katsu, T., Matsuo, I., Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides (2010) Bioorg. Med. Chem. Lett., 20, pp. 1771-1775; Nguyen, U.T., Wenderska, I.B., Chong, M.A., Koteva, K., Wright, G.D., Burrows, L.L., Small-molecule modulators of Listeria monocytogenes biofilm development (2012) Appl. Environ. Microbiol., 78 (5), pp. 1454-1465; Reffuveille, F., De La Fuente-Nunez, C., Mansour, S., Hancock, R.E., A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms (2014) Antimicrob. Agents Chemother., 58 (9), pp. 5363-5371; Rabin, N., Zheng, Y., Opoku-Temeng, C., Du, Y., Bonsu, E., Sintim, H.O., Agents that inhibit bacterial biofilm formation (2015) Future Med. Chem., 7 (5), pp. 647-671; Ribeiro, S.M., Felicio, M.R., Boas, E.V., Goncalves, S., Costa, F.F., Samy, R.P., Santos, N.C., Franco, O.L., New frontiers for antibiofilm drug development (2016) Pharmacol. Ther., 160, pp. 133-144; Brackman, G., Breyne, K., De Rycke, R., Vermote, A., Van Nieuwerburgh, F., Meyer, E., Van Calenbergh, S., Coenye, T., The quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release (2016) Sci. Rep., 6, pp. 20321-20335; De La Fuente-Nunez, C., Reffuveille, F., Haney, E.F., Strauss, S.K., Hancock, R., Broad-spectrum anti-biofilm peptide that targets a cellular stress response (2014) Plos Pathog, 10; Ho Sui, S.J., Fedynak, A., Hsiao, W.W., Langille, M.G., Brinkman, F.S., The association of virulence factors with genomic islands (2009) Plos One., 4; Rasko, D.A., Sperandio, V., Anti-virulence strategies to combat bacteria-mediated disease (2010) Nat. Rev. Drug Discov., 9, pp. 117-128; Schiago, G., Van Der Goot, G.F., The bacterial toxin tookit (2001) Nat. Rev. Mol. Cell Biol., 2, pp. 530-537; Costa, S.S., Viveiros, M., Amaral, L., Couto, I., Multidrug efflux pumps in Staphylococcus aureus: An update (2013) Open Microbiol. J., 7, pp. 59-71; Putman, M., Van Veen, H.W., Konings, W.N., Molecular properties of bacterial multidrug transporters (2000) Microbiol. Mol. Biol. Rev., 64 (4), pp. 672-693; Handzlik, J., Matys, A., Kieć-Kononowicz, K., Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Grampositive bacteria S. aureus (2013) Antibiotics, 2, pp. 28-45; Hassan, K.A., Liu, Q., Henderson, P.J., Paulsen, I.T., Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems (2015) Mbio, 6 (1); Fernando, D., Kumar, A., Resistance-nodulation-division multidrug efflux pumps in gram-negative bacteria: Role in virulence (2013) Antibiotics, 2, pp. 163-181; Spengler, G., Kincses, A., Gajdacs, M., Amaral, L., New roads leading to old destinations: Efflux pumps as targets to reverse multidrug resistance in bacteria (2017) Molecules, 22, pp. 468-493; Piddock, L.J.V., Multidrug-resistance efflux pumps-not just for resistance (2006) Nat. Rev. Microbiol., 4, pp. 629-636; Bambeke, F.V., Pages, J.M., Lee, V.J., Inhibitors of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostic tools for detection of resistance by efflux (2010) Front. Anti-Infec. Drug Dis., 1, pp. 138-175; Mousa, J.J., Bruner, S.T., Structural and mechanistic diversity of multidrug transporters (2016) Nat. Prod. Rep., 33, pp. 1255-1267; Schindler, B.D., Kaatz, G.W., Multidrug efflux pumps of Grampositive bacteria (2016) Drug Resist. Update, 27, pp. 1-13; Du, D., Van Veen, H.W., Murakami, S., Pos, K.M., Luisi, B.F., Structure, mechanism and cooperation of bacterial multidrug transporters (2015) Curr. Opin. Struct. Biol., 33, pp. 76-91; Law, C.J., Maloney, P.C., Wang, D.N., Ins and outs of major facilitator superfamily antiporters (2008) Annu. Rev. Microbiol, 62, pp. 289-305; Andersen, J.L., He, G.X., Kakarla, P., Ranjana, K.C., Kumar, S., Lakra, W.S., Mukherjee, M.M., Varela, M.F., Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens (2015) Int. J. Environ. Res. Public Health, 12, pp. 1487-1547; Kumar, S., Varela, M.F., Biochemistry of bacterial multidrug efflux pumps (2012) Int. J. Mol. Sci., 13, pp. 4484-4495; Yamada, Y., Shiota, S., Mizushima, T., Kuroda, T., Tsuchiya, T., Functional gene cloning and characterization of MdeA, a multidrug efflux pump from (2006) Staphylococcus Aureus. Biol. Pharm. Bull., 29, pp. 801-804; Gill, M.J., Brenwald, N.P., Wise, R., Identification of an efflux pump gene, pmra, associated with fluoroquinolone resistance (1999) Streptococcus Pneumoniae. Antimicrob. Agents Chemother., 43, pp. 187-189; Lee, E.W., Chen, J., Huda, M.N., Kuroda, T., Mizushima, T., Tsuchiya, T., Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis (2003) Biol. Pharm. Bull., 26, pp. 266-270; Davidson, A.L., Chen, J., ATP-binding cassette transporters in bacteria (2004) Annu. Rev. Biochem, 73, pp. 241-268; Rees, D.C., Johnson, E., Lewinson, O., ABC transporters: The power to change (2009) Nat. Rev. Mol. Cell Biol., 10 (3), pp. 218-227; Kobayashi, N., Nishino, K., Yamaguchi, A., Novel macrolidespecific ABC-type efflux transporter inEscherichia coli (2001) J. Bacteriol., 183, pp. 5639-5644; Borges-Walmsley, M.I., McKeegan, K.S., Walmsley, A.R., Structure and function of efflux pumps that confer resistance to drugs (2003) Biochem. J., 376, pp. 313-338; Li, X.Z., Nikaido, H., Efflux-mediated drug resistance in bacteria (2009) Drugs, 69 (12), pp. 1555-1623; McAleese, F., Petersen, P., Ruzin, A., Paul, M., Murphy, E., Projan, S.J., Patricia, A., Bradford, P.A., A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline (2005) Agents Chemother., 49, pp. 1865-1871; Kaatz, G.W., McAleese, F., Seo, S.M., Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein (2005) Antimicrob. Agents Chemother., 49, pp. 1857-1864; Kuroda, T., Tsuchiya, T., Multidrug efflux transporters in the MATE family (2009) Biochim. Biophys. Acta, 1794, pp. 763-768; Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., Tsuchiya, T., NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli (1998) Antimicrob. Agents Chemother., 42, pp. 1778-1782; Langton, K.P., Henderson, P.J., Herbert, R.B., Antibiotic resistance: Multidrug efflux proteins, a common transport mechanism (2005) Nat. Prod. Rep., 22, pp. 439-451; Arkin, I.T., Russ, W.P., Lebendiker, M., Schuldiner, S., Determining the secondary structure and orientation of EmrE, a multi-drug transporter, indicates a transmembrane four-helix bundle (1996) Biochemistry, 35, pp. 7233-7238; Schuldiner, S., Lebendiker, M., Yerushalmi, H., Emre, the smallest ion-coupled transporter, provides a unique paradigm for structurefunction studies (1997) J. Exp. Biol, 200, pp. 335-341; Masaoka, Y., Ueno, Y., Morita, Y., Kuroda, T., Mizushima, T., Tsuchiya, T.A., Two-component multidrug efflux pump, EbrAB, in Bacillus subtilis (2000) J. Bacteriol., 182, pp. 2307-2310; Narui, K., Noguchi, N., Wakasugi, K., Sasatsu, M., Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus (2002) Biol. Pharm. Bull., 25, pp. 1533-1536; Hassan, K.A., Jackson, S.M., Penesyan, A., Patching, S.G., Tetu, S.G., Eijkelkamp, B.A., Brown, M.H., Paulsen, I.T., Transcriptomic and biochemical analyses identify a family of chlorhexidine efflux proteins (2013) Proc. Natl. Acad. Sci. USA., 110 (50), pp. 20254-20259; Nikaido, H., Pages, J.M., Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria (2012) FEMS Microbiol. Rev., 36, pp. 340-363; Poole, K., Efflux pumps as antimicrobial resistance mechanisms (2007) Ann. Med., 39, pp. 162-176; Sulavik, M.C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., Di Domenico, B., Shimer, G., Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump gene (2001) Antimicrob. Agents Chemother., 45 (4), pp. 1126-1136; Li, X., Plesiat, P., Nikaido, H., The Challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria (2015) Clin. Microbiol.Rev., 28 (2), pp. 337-418; Koehler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L.K., Pechere, J.C., Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa (1997) Mol. Microbiol., 23, pp. 345-354; Adabi, M., Talebi-Taher, M., Arbabi, L., Afshar, M., Fathizadeh, S., Minaeian, S., Moghadam-Maragheh, N., Majidpour, A., Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitor (2015) Infect. Chemother., 47 (2), pp. 98-104; Massip, C., Descours, G., Ginevra, C., Doublet, P., Jarraud, S., Gilbert, C., Macrolide resistance in Legionella pneumophila: The role of LpeAB efflux pump (2017) J. Antimicrob. Chemother., 72 (5), pp. 1327-1333; Pan, Y.P., Xu, Y.H., Wang, Z.X., Fang, Y.P., Shen, J.L., Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa (2016) Arch. Microbiol., 198 (6), pp. 565-571; Schmitz, F.J., Hertel, B., Hofmann, B., Scheuring, S., Verhoef, J., Fluit, A.C., Heinz, H.P., Jones, M.E., Relationship between mutations in the coding and promoter regions of the norAgenes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains (1998) J. Antimicrob. Chemother., 42, pp. 561-563; Alcalde-Rico, M., Hernando-Amado, S., Blanco, P., Martinez, J.L., Multidrug efflux pumps at the crossroad between antibiotic resistance and bacterial virulence (2016) Front. Microbiol., 7, pp. 1483-1497; Yuhan, Y., Ziyun, Y., Yongbo, Z., Fuqiang, L., Qinghua, Z., Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and (2016) Klebsiella Pneumoniae. Rev. Soc. Bras. Med. Trop., 49 (2), pp. 165-171; Yang, H., Duan, G., Zhu, J., Lv, R., Xi, Y., Zhang, W., Fan, Q., Zhang, M., The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates (2008) Microb. Drug Resist., 14 (4), pp. 245-249; Perez, A., Poza, M., Fernandez, A., Fernandez Mdel, C., Mallo, S., Merino, M., Rumbo-Feal, S., Bou, G., Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of (2012) Enterobacter Cloacae. Antimicrob. Agents Chemother., 56 (4), pp. 2084-2090; Baucheron, S., Tyler, S., Boyd, D., Mulvey, M.R., Chaslus-Dancla, E., Cloeckaert, A., AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104 (2004) Antimicrob. Agents Chemother., 48 (10), pp. 3729-3735; Aixia Zhang, A., Rosner, J.L., Martin, R.G., Transcriptional activation by MarA, SoxS and Rob of two tolC promoters using one binding site: A complex promoter configuration for tolC in Escherichia coli (2008) Mol. Microbiol., 69 (6), pp. 1450-1455; Ruiz, C., Levy, S.B., Regulation of acrAB expression by cellular metabolites in Escherichia coli (2014) J. Antimicrob. Chemother., 69 (2), pp. 390-399; Swick, M.C., Morgan-Linnell, S.K., Carlson, K.M., Zechiedrich, L., Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance (2011) Antimicrob. Agents Chemother., 55 (2), pp. 921-924; Bergmiller, T., Andersson, A.M.C., Tomasek, K., Balleza, E., Kiviet, D.J., Hauschild, R., Tkačik, G., Guet, C.C., Biased partitioning of the multidrug efflux pump AcrAB-TolC underlies longlived phenotypic heterogeneity (2017) Science, 356 (6335), pp. 311-315; Laehnemann, D., Pena-Miller, R., Rosenstiel, P., Beardmore, R., Jansen, G., Schulenburg, H., Genomics of rapid adaptation to antibiotics: Convergent evolution and scalable sequence amplification (2014) Genome Biol. Evol., 6 (6), pp. 1287-1301; Yuan, J., Xu, X., Guo, Q., Zhao, X., Ye, X., Guo, Y., Wang, M., Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates (2012) J. Antimicrob. Chemother., 67 (7), pp. 1655-1659; Wong, M.H., Chan, E.W., Chen, S., Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae (2015) Antimicrob. Agents Chemother., 59 (6), pp. 3290-3297; Ho, P.L., Ng, K.Y., Lo, W.U., Law, P.Y., Lai, E.L., Wang, Y., Chow, K.H., Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli (2015) Antimicrob. Agents Chemother., 60 (1), pp. 537-543; Hansen, L.H., Jensen, L.B., Sorensen, H.I., Sorensen, S.J., Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria (2007) J. Antimicrob. Chemother., 60, pp. 145-147; Kim, H.B., Wang, M., Park, C.H., Kim, E.C., Jacoby, G.A., Hooper, D.C., OqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae (2009) Antimicrob. Agents Chemother., 53 (8), pp. 3582-3584; Rodriguez-Martinez, J.M., Diaz De Alba, P., Briales, A., Machuca, J., Lossa, M., Fernandez-Cuenca, F., Rodriguez Bano, J., Pascual, A., Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae (2013) J. Antimicrob. Chemother., 68 (1), pp. 68-73; Bialek-Davenet, S., Lavigne, J.P., Guyot, K., Mayer, N., Tournebize, R., Brisse, S., Leflon-Guibout, V., Nicolas-Chanoine, M.H., Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae (2015) J. Antimicrob. Chemother., 70, pp. 81-88; Worthington, R., Melander, C., Combination approaches to combat multidrug-resistant bacteria (2013) Trends Biotechnol., 31, pp. 177-184; Pages, J.M., Amaral, L., Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria (2009) Biochim. Biophys. Acta., 1794, pp. 826-833; Zgurskaya, H.I., Nikaido, H., Multidrug resistance mechanisms: Drug efflux across two membranes (2000) Mol Microbiol., 37, pp. 219-225; Pages, J.M., Masi, M., Barbe, J., Inhibitors of efflux pumps in Gram-negative bacteria (2005) Trends Mol. Med., 11, pp. 382-389; Marquez, B., Bacterial efflux systems and efflux pumps inhibitors Biochimie., 2005, 87, pp. 1137-1147; Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W.V., Pages, J.M., Antibiotic efflux pumps in Gram-negative bacteria: The inhibitor response strategy (2007) J Antimicrob Chemother., 59, pp. 1223-1229; Leger, R.L., Ving, J., She, M., (2001) Peptidomimetic Efflux Pump Inhibitors, , U.S. Patent 6204279 B1, March, 20; Leger, R.L., Ving, J., She, M., (2002) Peptidomimetic Efflux Pump Inhibitors, , U.S. Patent 6436980 B, Ago, 20; Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M.S., Boyer, E., Lee, V.J., Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa (1999) Antimicrob. Agents Chemother., 43, pp. 1340-1346; Bolla, J.M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boye, G., Kieć-Kononowicz,K.; Pages, J.M. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria (2011) FEBS Lett., 585, pp. 1682-1690; Opperman, T.J., Nguyen, S.T., Recent advances toward a molecular mechanism of efflux pump inhibition (2015) Front. Microbiol, 6 (421), pp. 1-16; Klyachko, K.A., Schuldiner, S., Neyfakh, A.A., Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr (1997) J. Bacteriol., 179, pp. 2189-2193; Baranova, N.N., Neyfakh, A.A., Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae (1997) Antimicrob. Agents Chemother., 41, pp. 1396-1398; Gibbons, S., Udo, E.E., The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(k) determinant (2000) Phytother. Res., 14, pp. 139-140; Stermitz, F.R., Lorenz, P., Tawara, J.N., Zenewicz, L.A., Lewis, K., Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor (2000) Proc. Natl. Acad. Sci., USA, 97, pp. 1433-1437; Novy, P., Rondevaldova, J., Kourimska, L., Kokoska, L., Synergistic interactions of epigallocatechin gallate and oxytetracycline against various drug resistant Staphylococcus aureus strains (2013) In Vitro. Phytomedicine, 20, pp. 432-435; Roccaro, A.S., Blanco, A.R., Giuliano, F., Rusciano, D., Enea, V., Epigallocatechingallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells (2004) Antimicrob. Agents Chemother., 48, pp. 1968-1973; Fujita, M., Shiota, S., Kuroda, T., Hatano, T., Yoshida, T., Mizushima, T., Tsuchiya, T., Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillinresistant Staphylococcus aureus (2005) Microbiol. Immunol., 49, pp. 391-396; Chan, B.C.L., Ip, M., Lau, C.B.S., Lui, S.L., Jolivalt, C., Carine Ganem-Elbaz, C., Litaudon, M., Leung, P.C., Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase (2011) J. Ethnopharm., 137, pp. 767-773; Chan, B.C.L., Ip, M., Gong, H., Lui, S.L., See, R.H., Jolivalt, C., Fung, K.P., Lau, C.B.S., Synergistic effects of diosmetin with erythromycin against ABC transporter overexpressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase (2013) Phytomedicine., 20, pp. 611-614; Renau, T.E., Leger, R., Yen, R., She, M.W., Flamme, E.M., Sangalang, J., Gannon, C.L., Lee, V.J., Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa (2002) Bioorg. Med. Chem. Lett., 12, pp. 763-766; Opperman, T.J., Kwasny, S.M., Kim, H.S., Nguyen, S.T., Houseweart, C., D’Souza, S., Walker, G.C., Bowlin, T.L., Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli (2014) Antimicrob. Agents Chemother., 58, pp. 722-733; Aron, Z., Opperman, T.J., Optimization of a novel series of pyranopyridine RND efflux pump inhibitors (2016) Curr. Opin. Microbiol., 33, pp. 1-6; Munoz-Bellido, J.L., Munoz-Criado, S., Garcia-Rodriguez, J.A., Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors (2000) Int. J. Antimicrob. Agents, 14, pp. 177-180; Kaatz, G.W., Moudgal, V.V., Seo, S.M., Hansen, J.B., Kristiansen, J.E., Phenylpiperidine selective serotonin reuptake inhibitors interferewith multidrug efflux pump activity in Staphylococcus aureus (2003) Int. J. Antimicrob. Agents, 22, pp. 254-261; German, N., Kaatz, G.W., Kerns, R.J., Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps (2008) Bioorg. Med. Chem. Lett., 18, pp. 1368-1373; Coelho, M.L., Ferreira, J.H.L., Siqueira-Junior, J.P., Kaatz, G.W., Barreto, H.M., Cavalcante, A.A.C.M., Inhibition of the NorA multidrug transporter by oxygenated monoterpenes (2016) Microb. Pathog., 99, pp. 173-177; Costa, L.M., Macedo, E.V., Oliveira, F.A.A., Ferreira, J.H.L., Gutierrez, S.J.C., Pelaez, W.J., Lima, F.C.A., Barreto, H.M., Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins (2016) J. Appl. Microbiol., 121, pp. 1312-1322; Whalen, K.E., Poulson-Ellestad, K.L., Deering, R.W., Rowley, D.C., Mincer, T.J., Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a pseudoalteromonas sp (2015) J. Nat. Prod., 78, pp. 402-412; Markham, P.N., Mulhearn, D.C., Neyfakh, A.A., Crich, D., Jaber, M.R., Johnson, M.E., (2002) Inhibitors of Multidrug Transporters, , U.S. Patent 6362229 B1, March, 26; Araujo, R.S.A., Barbosa-Filho, J.M., Scotti, M.T., Scotti, L., Cruz, R.M.D., Falcao-Silva, V.S., Siqueira-Junior, J.P., Mendonca Junior, F.J.B., Modulation of drug resistance in Staphylococcus aureus with coumarin derivatives (2016) Scientifica, 68, pp. 947-958; Brincat, J.P., Carosati, E., Sabatini, S., Manfroni, G., Fravolini, A., Raygada, J.L., Patel, D., Cruciani, G., Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus (2011) J. Med. Chem., 54, pp. 354-365; Kern, W.V., Steinke, P., Schumacher, A., Schuster, S., Von Baum, H., Bohnert, J.A., Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli (2006) J. Antimicrob. Chemother., 57, pp. 339-343; Schumacher, A., Steinke, P., Bohnert, J.A., Akova, M., Jonas, D., Kern, W.V., Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than (2006) Escherichia Coli. J. Antimicrob. Chemother., 57, pp. 344-348; Bohnert, J.A., Kern, W.V., Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps (2005) Antimicrob. Agents Chemother., 49, pp. 849-852; Lomovskaya, O., Warren, M.S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Lee, V.J., Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy (2001) Antimicrob. Agents Chemother., 45, pp. 105-116; Watkins, W.J., Landaverry, Y., Leger, R., Litman, R., Renau, T.E., Williams, N., Yen, R., Huie, K., Dudley. M.N. The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors (2003) Bioorg. Med. Chem. Lett., 13 (8), pp. 4241-4244; Renau, T.E., Leger, R., Flamme, E.M., Sangalang, J., She, M.W., Yen, R., Gannon, C.L., Nakayama, K., Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin (1999) J. Med. Chem., 42 (5), pp. 4928-4931; Renau, T.E., Leger, R., Flamme, E.M., She, M.W., Gannon, C.L., Mathias, K.M., Lomovskaya, O., Ishida, Y., Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa (2001) Bioorg. Med. Chem. Lett., 11, pp. 663-667; Lomovskaya, O., Bostian, K.A., Practical applications and feasibility of efflux pump inhibitors in the clinic -a vision for applied use (2006) Biochem. Pharmacol., 71, pp. 910-918; Klyachko, K.A., Schuldiner, S., Neyfakh, A.A., Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr (1997) J. Bacteriol., 179, pp. 2189-2193; Neyfakh, A.A., Borsch, C.M., Kaatz, G.W., Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter (1993) Antimicrob. Agents Chemother., 37, pp. 128-139; Hall, B.G., Barlow, M., Structure-based phylogenies of the serine beta-lactamases (2003) J. Mol. Evol., 57 (3), pp. 255-260; Pratt, R.F., β -Lactamases: Why and How (2016) J. Med. Chem., 59 (18), pp. 8207-8220; Hall, B.G., Barlow, M., Revised Ambler classification of β -lactamases (2005) J. Antimicrob. Chemother., 55 (6), pp. 1050-1051; Bush, K., Jacoby, G.A., Updated functional classification of β -lactamases (2010) Antimicrob. Agents Chemother., 54 (3), pp. 969-976; Garau, G., Di Guilmi, A.M., Hall, B.G., Structurebased phylogeny of the metallo-beta-lactamases (2005) Antimicrob. Agents Chemother., 49 (7), pp. 2778-2784; Rossolini, G.M., Docquier, J.D., New beta-lactamases: A paradigm for the rapid response of bacterial evolution in the clinical setting (2006) Future Microbiol., 1 (3), pp. 295-308; Evans, B.A., Amyes, S.G., OXA β -lactamases (2014) Clin. Microbiol. Rev., 27 (2), pp. 241-263; Brown, S., Young, H.K., Amyes, S.G.B., Characterization of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina (2005) Clin. Microbiol. Infect., 11, pp. 15-23; Dias, V.C., Resende, J.A., Bastos, N.A., Bastos, L.Q.A., Bastos, V.Q.A., Bastos, R.V., Diniz, C.G., Silva, V.L.D., Epidemiological, physiological, and molecular characteristics of a brazilian collection of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa (2017) Microb. Drug Resist, , February 24; Budak, S., Aktaş, Z., Oncul, O., Acar, A., Ozyurt, M., Turhan, V., Gorenek, L., Detection of OXA-51 carbapenemase gene in klebsiella pneumoniae: A case report and a new dimension on carbapenemase resistance (2013) J. Mol. Genet. Med., 7 (2), pp. 63-67; Bajpai, T., Pandey, M., Varma, M., Bhatambare, G.S., Prevalence of TEM, SHV, and CTX-M beta-lactamase genes in the urinary isolates of a tertiary care hospital (2017) Avicenna J. Med., 7 (1), pp. 12-16; Nogueira, K.S., Conte, D., Maia, F.V., Dalla-Costa, L.M., Distribution of extended-spectrum β-lactamase types in a Brazilian tertiary hospital (2015) Rev. Soc. Bras. Med. Trop., 48 (2), pp. 162-169; Baraniak, A., Fiett, J., Mrowka, A., Walory, J., Hryniewicz, W., Gniadkowski, M., Evolution of TEM-Type extended-spectrum β -lactamases in clinical Enterobacteriaceae strains in Poland (2005) Antimicrob. Agents Chemother., 49 (5), pp. 1872-1880; Jacoby, G.A., AmpC beta-lactamases (2009) Clin. Microbiol. Rev., 22 (1), pp. 161-182; Dantas, R.C.C., Silva, R.T.E., Ferreira, M.L., Goncalves, I.R., Araujo, B.F., Campos, P.A., Royer, S., Ribas, R.M., Molecular epidemiological survey of bacteremia by multidrug resistant (2017) Plos One, 12 (5); Ramirez, M.S., Tolmasky, M.E., Aminoglycoside modifying enzymes drug resist (2010) Updates, 13 (6), pp. 151-171; Van Hoek, A.H.A.M., Mevius, D., Guerra, B., Mullany, P., Roberts, A.P., Aarts, H.J.M., Acquired antibiotic resistance genes: An overview (2011) Front. Microbiol., 2, pp. 203-230; Krzymińska, S., Szczuka, E., Dudzińska, K., Kaznowski, A., Virulence and the presence of aminoglycoside resistance genes of Staphylococcus haemolyticus strains isolated from clinical specimens (2015) Antonie Van Leeuwenhoek, 107 (4), pp. 857-868; Heidary, M., Salimi Chirani, A., Khoshnood, S., Eslami, G., Atyabi, S.M., Nazem, H., Fazilati, M., Soleimani, S., Molecular detection of aminoglycoside-modifying enzyme genes in Acinetobacter baumannii clinical isolates (2016) Acta Microbiol. Immunol. Hung., 16, pp. 1-8; Abraham, E.P., Chain, E., An enzyme from bacteria able to destroy penicillin (1940) Nature, 146, p. 837; Fisher, J.F., Meroueh, S.O., Mobashery, S., Bacterial resistance to beta-lactam antibiotics: Compelling opportunism, compelling opportunity (2005) Chem. Rev., 105, pp. 395-424; Lewis, K., Platforms for antibiotic discovery (2013) Nat. Rev. Drug Disc., 12, pp. 371-387; Tsang, W.Y., Ahmed, N., Hinchliffe, P.S., Wood, J.M., Harding, L.P., Laws, A.P., Page, M.I., Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases (2005) J. Am. Chem. Soc., 127, pp. 17556-17564; Johnson, J.W., Evanoff, D.P., Savard, M.E., Lange, G., Ramadhar, T.R., Assoud, A., Taylor, N.J., Dmitrienko, G.I., Cyclobutanone Mimics of Penicillins: Effects of Substitution on Conformation and Hemiketal Stability (2008) J. Org. Chem., 73, pp. 6970-6982; Devi, P., (2015) Synthetic Approaches to a Peptide Isostere: Towards New β-Lactamase Inhibitors (Thesis), , The University of Sydney; Poole, K., Resistance to beta-lactam antibiotics (2004) Cell. Mol. Life Sci., 61, pp. 2200-2223; Drawz, S.M., Bonomo, R.A., Three Decades of β-Lactamase Inhibitors (2010) Clin. Microbiol. Rev., 23, pp. 160-201; Bush, K., β -Lactamase inhibitors from laboratory to clinic (1988) Clin. Microbiol. Rev., 1, pp. 109-123; Brown, A.G., Butterworth, D., Cole, M., Hanscomb, G., Hood, J.D., Reading, C., Rolinson, G.N., Naturally-occurring betalactamase inhibitors with antibacterial activity (1976) J. Antibiot., 29, pp. 668-669; Miller, L.A., Ratnam, K., Payne, D.J., Beta-lactamase-inhibitor combinations in the 21st century: Current agents and new developments (2001) Curr. Opin. Pharmacol., 1, pp. 451-458; Paterson, D.L., Resistance in gram-negative bacteria: Enterobacteriaceae (2006) Am. J. Infect. Control., 34, pp. S20-S28; Rasmussen, B.A., Bush, K., Carbapenem-hydrolyzing β-lactamases (1997) Antimicrob. Agents Chemother., 41, pp. 223-232; Yigit, H., Queenan, A.M., Rasheed, J.K., Biddle, J.W., Domenech-Sanchez, A., Alberti, S., Bush, K., Tenover, F.C., Carbapenem resistant strain of Klebsiella oxytoca harboring carbapenemhydrolyzing β -lactamase KPC-2 (2003) Antimicrob. Agents Chemother., 47, pp. 3881-3889; Imada, A., Kitano, K., Kintaka, K., Muroi, M., Asai, M., Sulfazecin and isosulfazecin, novel β -lactam antibiotics of bacterial origin (1981) Nature, 289, pp. 590-591; Sykes, R.B., Bonner, D.P., Bush, K., Georgopapadakou, N.H., Wells, J.S., Monobactams–monocyclic β -lactam antibiotics produced by bacteria (1981) J. Antimicrob. Chemother., 8, pp. 1-16; Sykes, R.B., Cimarusti, C.M., Bonner, D.P., Bush, K., Floyd, D.M., Georgopapadakou, N.H., Koster, W.M., Wells, J.S., Monocyclic β -lactam antibiotics produced by bacteria (1981) Nature, 291, pp. 489-491; Sykes, R.B., Bonner, D.P., Bush, K., Georgopapadakou, N.H., Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria (1982) Antimicrob. Agents Chemother., 21, pp. 85-92; Babini, G.S., Livermore, D.M., Effect of conalbumin on the activity of Syn 2190, a 1, 5 dihydroxy-4-pyridon monobactam inhibitor of AmpC β -lactamases (2000) J. Antimicrob. Chemother., 45, pp. 105-109; Nishida, K., Kunugita, C., Uji, T., Higashitani, F., Hyodo, A., Unemi, N., Maiti, S.N., Atwal, H., Micetich, R.G. In vitro and in vivo activities of Syn2190, a novel β-lactamase inhibitor (1999) Antimicrob. Agents Chemother., 43, pp. 1895-1900; Wright, G.D., The antibiotic resistome: The nexus of chemical and genetic diversity (2007) Nat. Rev. Microb., 5, pp. 175-186; Budzikiewicz, H., Siderophore-antibiotic conjugates used as Trojan horses against Pseudomonas aeruginosa (2001) Curr. Top. Med. Chem., 1, pp. 73-82; Powers, R.A., Caselli, E., Focia, P.J., Prati, F., Shoichet, B.K., Structures of ceftazidime and its transition-state analogue in complex with AmpC β-lactamase: Implications for resistance mutations and inhibitor design (2001) Biochemistry, 40, pp. 9207-9214; Trehan, I., Morandi, F., Blaszczak, L.C., Shoichet, B.K., Using steric hindrance to design new inhibitors of class C b-lactamases (2002) Chem. Biol., 9, pp. 971-980; Matagne, A., Ledent, P., Monnaie, D., Felici, A., Jamin, M., Raquet, X., Galleni, M., Frere, J.M., Kinetic study of interaction between BRL 42715, β -lactamases, and Dalanyl-D-alanine peptidases (1995) Antimicrob. Agents Chemother., 39, pp. 227-231; Bethel, C.R., Distler, A.M., Ruszczycky, M.W., Carey, M.P., Carey, P.R., Hujer, A.M., Taracila, M., Bonomo, R.A., Inhibition of OXA-1 β -lactamase by penems (2008) Antimicrob. Agents Chemother., 52, pp. 3135-3143; Iglicar, P., Legen, I., Vilfan, G., Selic, L., Prezelj, A., Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro (2009) J. Pharm. Pharmacol., 61, pp. 1211-1218; Titelmana, E., Karlssonb, I.M., Gec, Y., Giskeb, C.G., In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14 and CTX-M-15–producing Escherichia coli and Klebsiella pneumonia (2011) Diagnost. Microb. Infect. Dis., 70, pp. 137-141; Biondi, S., Long, S., Panunzio, M., Qin, W.L., Current Trends in β-Lactam Based β -Lactamases Inhibitors (2011) Curr. Med. Chem., 18, pp. 4223-4236; J.D. β-Lactamase inhibitors: A review of the patent literature 2010-2013 (2013) Expert Opin. Ther. Patents., 23, pp. 1469-1481. , Buynak; Crandon, J.L., Schuck, V.J., Banevicius, M.A., Beaudoin, M.E., Nichols, W.W., Tanudra, M.A., Nicolau, D.P., Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa (2012) Antimicrob. Agents Chemother., 56, pp. 6137-6146; Watkins, R.R., Papp-Wallace, K.M., Drawz, S.M., Bonomo, R.A., Novel β -lactamase inhibitors: A therapeutic hope against the scourge of multidrug resistance (2013) Front. Microb, 4 (392), pp. 1-8; Ledoussal, B., Gourdel, M.E., Preparation of Azabicycles as Inhibitors of Beta-Lactamases and Their Use in Pharmaceutical Compositions Containing Beta-Lactam Antibiotics, , FR Patent. 2930553, 2009; Ledoussal, B., Gourdel, M.E., (2009) Preparation of Azabicycles as Inhibitors of Beta-Lactamases and Their Use in Pharmaceutical Compositions Containing Beta-Lactam Antibiotics, , WO Patent 2009133442, Novemberm 5; Patil, V.T., Tadiparthi, R., Birajdar, S., Bhagwat, S., (2013) Preparation of Trans-7-Oxo-6-(Sulfoxy)-1,6-Diazabicyclo[3.2.1]Octane-2-Carbonitrile Salts for the Treatment of Bacterial Infections, , WO Patent 2013038330; Evan, J., Rybak, Z.J.M., Rybak, M.J., The β-Lactams Strike Back: Ceftazidime-Avibactam (2015) Pharmacother, 35 (8), pp. 755-770; Kiener, P.A., Waley, S.G., Reversible inhibitors of penicillinases (1978) Biochem. J., 169, pp. 197-204; Hirst, G., Reddy, R., Hecker, S., Totrov, M., Griffith, D.C., Rodny, O., Dudley, M.N., Boyer, S., (2012) Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof, , US Patent 20120040932 A1, Ferbuary, 12; Livermore, D.M., Mushtaq, S., Activity of biapenem (RPX2003) combined with the boronate β -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae (2013) J. Antimicrob. Chemother., 68, pp. 1825-2183; Prati, F., Caselli, E., (2013) Boronic Acid Inhibitors of Beta-Lactamases as Therapeutic Agents in Treatment of Antibiotic-Resistant Infection Diseases, , WO Patent 2013053372 A1, April, 18; Mobashery, S., Hesek, D., (2011) Chang, M. Preparation of Phthalanilate and Related Compounds as Antibacterial Agents, , WO Patent 2011026107, March, 3; Kristiansen, M.M., Leandro, C., Ordway, D., Martins, M., Viveiros, M., Pacheco, T., Kristiansen, E., Amaral, L., Phenothiazines alter resistance of methicillin resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro (2003) Int. J. Antimicrob. Agents., 22, pp. 250-253; Kong, R., Kang, O.H., Seo, Y.S., Mun, S.H., Zhou, T., Shin, D.W., Kwon, D.Y., The inhibition effect of Chlorpromazine against the β-lactam resistance of MRSA (2016) Asian. Pac. J. Trop. Med., 9 (6), pp. 542-546; Grigorenko, V.G., Andreeva, I.P., Rubtsova, W.Y., Deygen, I.M., Antipin, R.L., Majouga, A.G., Egorov, A.M., Hackenberg, C., Novel non-b-lactam inhibitor of β -lactamase TEM-171 based on acylated phenoxyaniline (2017) Biochim., 132, pp. 45-53; Daiyasu, H., Osaka, K., Ishino, Y., Toh, H., Expansion of the zinc metallo-hydrolase family of the β-lactamase fold (2001) FEBS Lett., 503, pp. 1-6; Nagano, R., Adachi, Y., Hashizume, T., Morishima, H., In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1β-methylcarbapenem, against transferable IMP-1 metallo-β-lactamase producers (2000) J. Antimicrob. Chemother., 45, pp. 271-276; Buynak, J.D., Chen, H., Vogeti, L., Gadhachanda, V.R., Buchanan, C.A., Palzkill, T., Shaw, R.W., Walsh, T.R., Penicillinderived inhibitors that simultaneously target both metallo-and serine-β-lactamases (2004) Bioorg. Med. Chem. Lett., 14, pp. 1299-1304; Toney, J.H., Hammond, G.G., Fitzgerald, P.M., Sharma, N., Balkovec, J.M., Rouen, G.P., Olson, S.H., Gao, Y.D., Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase (2001) J. Biolog. Chem., 276, pp. 31913-31918; Meiji, S.K., (2009) Pharmaceutical Compositions Containing Maleic Acid Derivatives and Cephem Antibiotics, , JP Patent, 2009040743; (2009) Preparation of Naphthohydrazides, Benzohydrazides and Pyridohydrazides as Inhibitors of Class B and Class D Beta-Lactamases, , WO Patent 2009114921; Yong, D., Toleman, M.A., Giske, C.G., Cho, H.S., Sundman, K., Lee, K., Walsh, T.R., Characterization of a new metallo-β -lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India (2009) Antimicrob. Agents Chemother, 53, pp. 5046-5054; Singh, A., Science, names giving and names calling: Change NDM-1 to PCM (2011) Mens. Sana. Monogr., 9, pp. 294-319; Pollini, S., Maradei, S., Pecile, P., Olivo, G., Luzzaro, F., Docquier, J.D., Rossolini, G.M., FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy (2013) Antimicrob. Agents Chemother, 57, pp. 410-416; Christopeit, T., Albert, A., Leiros, H.K.S., Discovery of a novel covalent non-b-lactam inhibitor of the metallo-β -lactamase NDM-1 (2016) Bioorg. Med. Chem., 24, pp. 2947-2953; Zhai, L., Zhang, Y.L., Kang, J.S., Oelschlaeger, P., Xiao, L., Nie, S.S., Yang, K.W., Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors (2016) ACS Med. Chem. Lett., 7, pp. 413-417; Groundwater, P.W., Xu, S., Lai, F., Váradi, L., Tan, J., Hibbs, D.E., New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers (2016) Future Med. Chem., 8, pp. 1-12; Gan, M., Liu, Y., Bai, Y., Guan, Y., Li, L., Gao, R., He, W., Xiao, C., Polyketides with New Delhi metallobeta-lactamase 1 inhibitory activity from Penicillium sp (2013) J. Nat. Prod., 76, pp. 1535-1540; Thomas, P.W., Spicer, T., Cammarata, M., Brodbelt, J.S., Hodder, P., Fast, W., An altered zinc-binding site confers resistance to a covalent inactivator of New Delhi metallo-beta-lactamase-1 (NDM-1) discovered by high-throughput screening (2013) Bioorg. Med. Chem., 21, pp. 3138-3146; Chiou, J.C., Wan, S.B., Chan, K.F., So, P.K., He, D., Chan, E.W., Chan, T.H., Chen, S., Ebselen as a potent covalent inhibitor of New Delhi metallo-beta-lactamase (NDM-1) (2015) Chem. Commun., 51, pp. 9543-9546; Chen, X., Hu, X., Wu, Y., Liu, Y., Bian, C., Nie, T., You, X., Hu, L., Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria (2017) Bioorg. Med. Chem. Lett., 27 (4), pp. 841-844; Rutherford, S.T., Bassler, B.L., Bacterial quorum sensing: Its role in virulence and possibilities for its control (2012) Cold Spring Harb. Perspect Med, 2 (11); Ruer, S., Pinotsis, N., Steadman, D., Waksman, G., Remaut, H., Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms (2015) Chem. Biol. Drug Des., 86 (4), pp. 379-399; Allen, R.C., Popat, R., Diggle, S.P., Brown, S.P., Targeting virulence: can we make evolution-proof drugs? (2014) Nat. Rev. Microbiol., 12 (4), pp. 300-308; Rutherford, S.T., Bassler, B.L., Bacterial quorum sensing: Its role in virulence and possibilities for its control (2012) Cold Spring Harb. Perspect. Med, 2 (11); Ruer, S., Pinotsis, N., Steadman, D., Waksman, G., Remaut, H., Virulence-targeted Antibacterials: Concept, promise, and susceptibility to resistance mechanisms (2015) Chem. Biol. Drug Des., 86 (4), pp. 379-399; Maeda, T., Garcia-Contreras, R., Pu, M., Sheng, L., Garcia, L.R., Tomas, M., Wood, T.K., Quorum quenching quandary: Resistance to antivirulence compounds (2012) ISME J., 6 (3), pp. 493-501; Garcia-Contreras, R., Perez-Eretza, B., Jasso-Chavez, R., Lira-Silva, E., Roldan-Sanchez, J.A., Gonzalez-Valdez, A., Soberon-Chavez, G., Wood, T.K., High variability in quorum quenching and growth inhibition by furanone C-30 (2015) Pathog. Dis, 73 (6); Gerdt, J.P., Blackwell, H.E., Competition studies confirm two major barriers that can preclude the spread of resistance to quorumsensing inhibitors in bacteria (2014) ACS Chem. Biol., 9 (10), pp. 2291-3229; Fernebro, J., Fighting bacterial infections – future treatment options (2011) Drug Resist. Update., 14, pp. 125-139; Kamal, A.A.M., Petrera, L., Eberhard, J., Hartmann, R.W., Structure-functionality relationship and pharmacological profiles of Pseudomonas aeruginosa alkylquinolone quorum sensing modulators (2017) Org. Biomol. Chem., 15 (21), pp. 4620-4630; Tiwary, B.K., Ghosh, R., Moktan, S., Ranjan, V.K., Dey, P., Choudhury, D., Dutta, S., Chakraborty, R., Prospective bacterial quorum sensing inhibitors from Indian medicinal plant extracts (2017) Lett. Applied Microb., 65 (1), pp. 2-10; Borges, A., Abreu, A.C., Dias, C., Saavedra, M.J., Borges, F., Simoes, M., New perspectives on the use of phytochemicals as an emergent strategy to control bacterial infections including biofilms (2016) Molecules, 21 (7), pp. 1-41; Nandakumar, N., Dandela, R., Gopas, J., Meijler, M.M., Quorum sensing modulators exhibit cytotoxicity in Hodgkin's lymphoma cells and interfere with NF-kappa B signaling (2017) Bioorg. Med. Chem. Lett., 27 (13), pp. 2967-2973; O’Loughlin, C.T., Miller, L.C., Siryaporn, A., Drescher, K., Semmelhack, M.F., Bassler, B.L., A quorumsensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 17981-17986; Tan, S.Y., Chua, S.L., Chen, Y., Rice, S.A., Kjelleberg, S., Nielsen, T.E., Yang, L., Givskov, M., Identification of five structurally nrelated quorum-sensing inhibitors of Pseudomonas aeruginosa from a naturalderivative database (2013) Antimicrob. Agents Chemother., 11, pp. 5629-5641; Sully, E.K., Malachowa, N., Elmore, B.O., Alexander, S.M., Femling, J.K., Gray, B.M., Deleo, F.R., Gresham, H.D., Selective chemical inhibition of agr quorum sensing (2014) Plos Pathog, 10; Hentzer, M., Riedel, K., Rasmussen, T.B., Heydorn, A., Andersen, J.B., Parsek, M.R., Rice, S.A., Givskov, M., Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound (2002) Microb., 148, pp. 87-102; Christensen, Q.H., Grove, T.L., Booker, S.J., Greenberg, E.P., A high-throughput screen for quorumsensing inhibitors that target acyl-homoserine lactone synthases (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 13815-13820; Anantharajah, A., Buyck, J.M., Sundin, C., Tulkens, P.M., Mingeot-Ledercq, M.P., Van Bambeke, F., Salicylidene acylhydrazides and hydroxyquinolines act as inhibitors of type three secretion systems in Pseudomonas aeruginosa by distinct mechanisms (2017) Antimicrob. Agents Chemother., 61 (6). , e02566-16; Duncan, M.C., Herrera, N.G., Johnson, K.S., Engel, J.N., Auerbuch, V., Bacterial internalization is required to trigger NIKdependent NF-kappa B activation in response to the bacterial type three secretion system (2017) Plos One, 12 (2); Fan, S.S., Tian, F., Li, J.Y., Hutchins, W., Chen, H.M., Yang, F.H., Yuan, X.C., He, C.Y., Identification of phenolic compounds that suppress the virulence of Xanthomonas oryzae on rice via the type III secretion system (2017) Mol. Plant Pathol., 18 (4), pp. 555-568; Moir, D.T., Di, M., Wong, E., Moore, R.A., Schweizer, H.P., Woods, D.E., Bowlin, T.L., Development and application of a cellular, gainof-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei (2011) J. Biomol. Screen., 16, pp. 694-705; Yamazaki, A., Li, J., Zeng, Q., Khokhani, D., Hutchins, W.C., Yost, A.C., Biddle, E., Yang, C.H., Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system (2012) Antimicrob. Agents Chemother., 56, pp. 36-43; Tree, J.J., Wang, D., McInally, C., Mahajan, A., Layton, A., Houghton, I., Elofsson, M., Roe, A.J., Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion inEscherichia coli O157:H7 (2009) Infect. Immun., 77, pp. 4209-4220; Kimura, K., Iwatsuki, M., Nagai, T., Matsumoto, A., Takahashi, Y., Shiomi, K., Omura, S., Abe, A., A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium (2011) J. Antibiot., 64, pp. 197-203; Yarlagadda, V., Manjunath, G.B., Sarkar, P., Akkapeddi, P., Paramanandham, K., Shome, B.R., Ravikumar, R., Haldar, J., Glycopeptide antibiotic to overcome the intrinsic resistance of Gramnegative bacteria (2016) ACS Infect. Dis., 2 (2), pp. 132-139; Dinesh, N., Sharma, S., Balganesh, M., Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosis (2013) Antimicrob. Agents Chemother., 57 (4), pp. 1941-1943; Martinsa, M., McCuskera, M.P., Viveiros, M., Coutoc, I., Fanninga, S., Jean-Pages, M., Amaral, L., A simple method for assessment of MDR bacteria for over-expressed efflux pumps (2013) Open Microbiol. J., 7, pp. 72-82; Moya-Torres, A., Mulvey, M.R., Kumar, A., Oresnik, I.J., Brassinga, A.K., The lack of OmpF, but not OmpC, contributes to increased antibiotic resistance in Serratia marcescens (2014) Microbiol., 160, pp. 1882-1892; Lin, Q.Y., Tsai, Y.L., Liu, M.C., Lin, W.C., Hsueh, P.R., Liaw, S.J., Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance (2014) Antimicrob. Agents Chemother., 58 (9), pp. 5181-5190; Nikaido, H., Molecular basis of bacterial outer membrane permeability revisited (2003) Microbiol. Mol. Biol. Rev., 67 (4), pp. 593-656; Stenkova, A.M., Bystritskaya, E.P., Guzev, K.V., Rakin, A.V., Isaeva, M.P., Molecular evolution of the Yersinia major outer membrane protein C (OmpC) (2016) Evol. Bioinform. Online, 12, pp. 185-191; Ghai, I., Winterhalter, M., Wagner, R., Probing transport of charged β-lactamase inhibitors through OmpC, a membrane channel from (2017) E. Coli. Biochem. Biophys. Res. Commun., 484 (1), pp. 51-55; Jaffe, A., Chabbert, Y.A., Semonin, O., Role of porin proteins OmpF and OmpC in the permeation of beta-lactams (1982) Antimicrob. Agents Chemother., 22 (6), pp. 942-948; Lou, H., Chen, M., Black, S.S., Bushell, S.R., Ceccarelli, M., Mach, T., Beis, K., Naismith, J.H., Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant (2011) E. Coli. Plos One, 6 (10); Bajaj, H., Scorciapino, M.A.L., Page, M.G.P., Naismith, J.H., Ceccarelli, M., Winterhalter, M., Molecular basis of filtering carbapenems by porins from β -lactam-resistant clinical strains of Escherichia coli (2016) J. Biol. Chem., 291 (6), pp. 2837-2847; Harder, K.J., Nikaido, H., Matsuhashi, M., Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin (1981) Antimicrob. Agents Chemother., 20 (4), pp. 549-552; Tsai, Y.K., Fung, C.P., Lin, J.C., Chen, J.H., Chang, F.Y., Chen, T.L., Siu, L.K., Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence (2011) Antimicrob. Agents Chemother., 55 (4), pp. 1485-1493; Pages, J.M., James, C.E., Winterhalter, M., The porin and the permeating antibiotic: A selective diffusion barrier in Gram-negative bacteria (2008) Nat. Ver. Microbiol., 6 (12), pp. 893-903; Phan, K., Ferenci, T., The fitness costs and trade-off shapes associated with the exclusion of nine antibiotics by OmpF porin channels (2017) ISME J., 11, pp. 1472-1482; Li, H., Luo, Y.F., Williams, B.J., Blackwell, T.S., Xie, C.M., Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies (2012) Int. J. Med. Microbiol., 302 (2), pp. 63-68; Ochs, M.M., McCusker, M.P., Bains, M., Hancock, R.E.W., Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids (1999) Antimicrob. Agents Chemother., 43 (5), pp. 1085-1090; Ocampo-Sosa, A.A., Cabot, G., Rodriguez, C., Roman, E., Tubau, F., Macia, M.D., Moya, B., Martinez-Martinez, L., Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish Multicenter Study (2012) Antimicrob. Agents Chemother., 56 (4), pp. 1703-1713; Catel-Ferreira, M., Nehme, R., Molle, V., Aranda, J., Bouffartigues, E., Chevalier, S., Bou, G., De, E., Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii (2012) Antimicrob. Agents Chemother., 56 (7), pp. 3826-3832; Fernandez-Cuenca, F., Smani, Y., Gomez-Sanchez, M.C., Docobo-Perez, F., Caballero-Moyano, F.J., Dominguez-Herrera, J., Pascual, A., Pachon, J., Attenuated virulence of a slow-growing pandrugresistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like (2011) Int. J. Antimicrob. Agents, 38, pp. 548-549; Kidd, T.J., Mills, G., Sa-Pessoa, J., Dumigan, A., Frank, C.G., Insua, J.L., Ingram, R., Bengoechea, J.A., A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence (2017) EMBO Mol. Med., 9 (4), pp. 430-447; Hitchen, P.G., Prior, J.L., Oyston, P.C., Panico, M., Wren, B.W., Titball, R.W., Morris, H.R., Dell, A., Structural characterization of lipo-oligosaccharide (LOS) from Yersinia pestis: Regulation of LOS structure by the PhoPQ system (2002) Mol. Microbiol., 44 (6), pp. 1637-1650; Murata, T., Tseng, W., Guina, T., Miller, S.I., Nikaido, H., PhoPQmediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium (2007) J. Bacteriol., 189 (20), pp. 7213-7222; Overgaard, M., Kallipolitis, B., Valentin-Hansen, P., Modulating the bacterial surface with small RNAs: A new twist on PhoP/Qmediated lipopolysaccharide modification (2009) Mol. Microbiol., 74 (6), pp. 1289-1294; Rhodes, K.A., Schweizer, H.P., Antibiotic resistance in Burkholderia species (2016) Drug Resist. Update., 28, pp. 82-90; Beceiro, A., Tomas, M., Bou, G., Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? (2013) Clin. Microbiol. Rev., 26 (2), pp. 185-230; Malouin, F., Bryan, L.E., Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance (1986) Antimicrob. Agents Chemother., 30 (1), pp. 1-5; Katayama, Y., Ito, T., Hiramatsu, K.A., New class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus (2000) Antimicrob. Agents Chemother., 44, pp. 1549-1555; Medhus, A., Slettemeas, J.S., Marstein, L., Larssen, K.W., Sunde, M., Methicillin-resistant Staphylococcus aureus with the novel mecC gene variant isolated from a cat suffering from chronic conjunctivitis (2013) J. Antimicrob. Chemother., 68, pp. 968-969; Ballhausen, B., Kriegeskorte, A., Schleimer, N., Peters, G., Becker, K., The mecA homolog mecC confers resistance against β-Lactams in Staphylococcus aureus irrespective of the genetic strain background (2014) Antimicrob. Agents Chemother., 58 (7), pp. 3791-3798; Fontana, R., Aldegheri, M., Ligozzi, M., Lopez, H., Sucari, A., Satta, G., Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium (1994) Antimicrob. Agents Chemother., 38 (9), pp. 1980-1983; Arbeloa, A., Segal, H., Hugonnet, J.E., Josseaume, N., Dubost, L., Brouard, J.P., Gutmann, L., Arthur, M., Role of class A penicillin-binding proteins in PBP5-mediated betalactam resistance in Enterococcus faecalis (2004) J. Bacteriol., 186 (5), pp. 1221-1228; Rice, L.B., Carias, L.L., Rudin, S., Hutton, R., Marshall, S., Hassan, M., Josseaume, N., Arthur, M., Role of class A penicillin-binding proteins in the expression of beta-lactam resistance in Enterococcus faecium (2009) J. Bacteriol., 191 (11), pp. 3649-3656; Hoff, J.S., Kristich, C.J., Thymidylate limitation potentiates cephalosporin activity toward enterococci via an Exopolysaccharidebased mechanism (2016) ACS Chem. Biol., 11 (6), pp. 1561-1568; Sun, S., Selmer, M., Andersson, D.I., Resistance to β-lactam antibiotics conferred by point mutations in penicillin-binding proteins PBP3, PBP4 and PBP6 in Salmonella enterica (2014) Plos One, 9 (5); Dabernat, H., Delmas, C., Seguy, M., Pelissier, R., Faucon, G., Bennamani, S., Pasquier, C., Diversity of β -lactam resistanceconferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenza (2002) Antimicrob. Agents Chemother., 46 (7), pp. 2208-2218; Cayo, R., Rodriguez, M., Espinal, P., Fernandez-Cuenca, F., Ocampo-Sosa, A.A., Pascual, A., Ayala, J.A., Martinez-Martinez, L., Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii (2011) Antimicrob. Agents Chemother., 55 (12), pp. 5907-5913; Ropp, P.A., Hu, M., Olesky, M., Nicholas, R.A., Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae (2002) Antimicrob. Agents Chemother., 46 (3), pp. 769-777; Aldred, K.J., Kerns, R.J., Osherof, N., Mechanism of quinolone action and resistance (2014) Biochemistry, 53, pp. 1565-1574; Correia, S., Poeta, P., Hebraud, M., Capelo, J.L., Igrejas, G., Mechanisms of quinolone action and resistance: where do we stand? (2017) J. Med. Microbiol., 66 (5), pp. 551-559; Kogaluru, S.S., Vijaya, K.D., Moleyuru, N.V., Karunasagar, I., Karunasagar, I., Multiple antimicrobial resistance and novel point mutation in fluoroquinolone-resistant Escherichia coli isolates from Mangalore, India (2017) Microb. Drug Resist., pp. 1-8; Lautenbach, E., Metlay, J.P., Mao, X., Fishman, N.O., Bilker, W.B., Tolomeo, P., Wheeler, M., Nachamkin, I., The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients (2010) Clin. Infect Dis., 51 (3), pp. 280-285; Gorgani, N., Ahlbrand, S., Patterson, A., Pourmand, N., Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa (2009) Int. J. Antimicrob. Agents, 34 (5), pp. 414-418